"Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial" by Minesh Mehta

Article

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial

JAMA Oncology

Minesh Mehta, Miami Cancer Institute

Download Find in your library

Publication Date

10-1-2018

Content Type

application/pdf

PubMed ID:

29955793

Additional Authors:

Additional authors and institutional affiliations

Citation Information

JAMA Oncol (2018) 4(10):1405-1409